Researchmoz Global Pvt. Ltd.

At a CAGR of 8.6% Global Solid Tumors Drugs Industry Will Grow Steadily During the Period 2016-2020

Researchmoz added Most up-to-date research on "Global Solid Tumors Drugs Market 2016-2020" to its huge collection of research reports.


Albany, NY -- (SBWIRE) -- 01/17/2017 -- The rising prevalence of various cancers, which has led to innovations and technological advancements, drives the development of new immunotherapy drugs that are more effective than the available drugs to treat solid tumors.
Solid tumors are an abnormal mass of tissue that do not contain cysts or liquid areas. These may be malignant (cancerous) or benign (not cancerous). They affect bones, organs, and muscles. Based on the type of the cells, solid tumors can be carcinomas, sarcomas, and lymphomas.

Technavios analysts forecast the global solid tumors drugs market to grow at a CAGR of 8.6% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global solid tumors drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded drugs, generics, and biosimilars used to treat solid tumors. It also considers the revenues to be generated from the sales of drugs that are anticipated to be launched into the market along with the decline in revenues from the patent expiries of the branded drugs during the forecast period.

The market is divided into the following segments based on geography:

To Get Sample Copy of Report visit @

Technavio's report, Global Solid Tumors Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
F. Hoffmann-La Roche
Johnson & Johnson

Other prominent vendors
ADC Therapeutics
Almac Group
Argos Therapeutics
Array BioPharma
Astellas Pharma
Biotech Pharmaceutical
Boehringer Ingelheim
Boston Biomedical
Celldex Therapeutics
Chugai Pharmaceutical
Cold Genesys
CTI BioPharma
Daiichi Sankyo
Eleison Pharmaceuticals
Eli Lilly
Endo Pharmaceuticals
Formation Biologics
Fortress Biotech
Immatics Biotechnologies
Intas Pharmaceuticals
Kairos Therapeutics
Kyowa Hakko Kirin
Mersana Therapeutics
Neovii Biotech
NewLink Genetics
Northwest Biotherapeutics
OncoMed Pharmaceuticals
Oxford Biotherapeutics
Peregrine Pharmaceuticals
Polaris Pharmaceuticals
Seattle Genetics
Spectrum Pharmaceuticals
Synthon Biopharmaceuticals
TG Therapeutics

Market driver
Exposure to risk factors
For a full, detailed list, view our report

Market challenge
Patent expiration of top-selling drugs
For a full, detailed list, view our report

Market trend
Emergence of targeted and combination therapies
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @

About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:

Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948

Follow us on LinkedIn @